Bartlett, M. S.

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 855

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

Espinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C., Fothergill, A., McGinnis, M. R., Menezes, P., Messer, S. A., Nelson, P. W., et al. (1997) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 228

Dihydropteroate synthase polymorphisms in Pneumocystis carinii.

Lane, B. R., Ast, J. C., Hossler, P. A., Mindell, D. P., Bartlett, M. S., Smith, J. W., & Meshnick, S. R. (1997) · Journal of Infectious Diseases

Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory Infections

Cited by 176

Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.

Kazanjian, P., Locke, A. B., Hossler, P. A., Lane, B. R., Bartlett, M. S., Smith, J. W., Cannon, M., & Meshnick, S. R. (1998) · AIDS

Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory Infections

Cited by 171

Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation

Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 83